Coultreon Biopharma
PrivateLast Round
Series A
Apr 28, 2026
Total Funding Raised
$148.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Coultreon Biopharma is a biotechnology company that develops therapies targeting clinically-validated pathways across immunology and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coultreon Biopharma Comparables
Compare Coultreon Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sitryx | 79% | |
| Galapagos NV | 69% | |
| AbbVie | 67% | |
Coultreon Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 28, 2026 | ||||
| Seed | Apr 1, 2025 |
Coultreon Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Balyasny Asset Management L.P. | Series A |
| Finchley Healthcare Ventures | Series A |
| Forbion | Series A |
| Novo Holdings | Series A |
| Galapagos NV | Series A, Seed |
| Longwood Fund | Series A |
| Samsara BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 4, 2026
Grew 36% QoQ, from 22 to 30 employees.
- Jun 26, 2026
Grew 36% QoQ, from 22 to 30 employees.
Coultreon Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Coultreon Biopharma's valuation, stock price, and market status.